|
2021
|
Invention
|
Prolyl hydroxylase inhibitors.
Disclosed herein are prolyl hydroxylase inhibitors that can stabi... |
|
2019
|
Invention
|
Methods of treating diabetic nephropathy using hptpß inhibitors. Disclosed herein are compounds e... |
|
2018
|
Invention
|
Prolyl hydroxylase inhibitors. Disclosed herein are prolyl hydroxylase inhibitors that can stabil... |
|
2017
|
Invention
|
Humanized monoclonal antibodies that target ve-ptp (hptp-ß). The disclosure provides compositions... |
|
2016
|
Invention
|
Methods of treating intraocular pressure with activators of tie-2. Disclosed herein are compounds... |
|
2015
|
Invention
|
Ve-ptp extracellular domain antibodies delivered by a gene therapy vector. The disclosure provide... |
|
|
Invention
|
Combination of immunotherapies with activators of tie-2. The present invention relates to combina... |
|
|
Invention
|
Hptp-beta inhibitors. Disclosed herein are compounds effective for activation of Tie-2 and inhibi... |
|
|
Invention
|
Methods for increasing the stabilization of hypoxia inducible factor-α. Disclosed herein are meth... |
|
|
Invention
|
Process for preparing n-benzyl-3-hydroxy-4-substituted-pyridin-2-(1h)-ones. Disclosed herein is a... |
|
2014
|
Invention
|
Methods for increasing the stabilization of hypoxia inducible factor-1 alpha. Disclosed herein ar... |
|
|
Invention
|
Compositions, formulations and methods for treating ocular diseases. Disclosed herein are compoun... |
|
2012
|
Invention
|
Methods for treating vascular leak syndrome and cancer. Disclosed are methods for treating Vascul... |
|
|
Invention
|
Treatment of ocular disease. Disclosed are methods for treating eye diseases or conditions charac... |
|
2011
|
Invention
|
Compositions and methods for treating ocular edema, neovascularization and related diseases. Disc... |
|
|
Invention
|
Compositions and methods for treating ocular edema, neovascularization and related diseases.
|
|
2010
|
Invention
|
Compositions and methods for treating colitis. Disclosed herein are compositions and methods for ... |
|
|
Invention
|
Prolyl hydroxylase inhibitors.
Disclosed herein are prolyl hydroxylase inhibitor... |
|
|
Invention
|
Compositions comprising n-benzyl or n-sulfonylaryl-3-hydroxypyridin-2-(1h)-ones and their use for... |
|
|
Invention
|
N-benzyl-4-methyleneamino-3-hydroxy-2-pyridones. Compounds of Formula (I)
are effective in the ... |
|
|
Invention
|
Compounds, compositions, and methods for preventing metastasis of cancer cells.
D... |
|
2007
|
Invention
|
N-alkyl-4-methyleneamino-3-hydroxy-2-pyridones. Compounds of Formula (I):
are effective in the ... |
|
2005
|
Invention
|
N-sulfonyl-4-methyleneamino-3-hydroxy-2-pyridones. Compounds of Formula (I)
are effective in th... |
|
|
Invention
|
N-alkyl-4-methyleneamino-3-hydroxy-2-pyridones. Compounds of Formula (I)
are effective in the t... |
|
2003
|
Invention
|
N-sulfonyl-4-methyleneamino-3-hydroxy-2-pyridones as antimicrobial agents.
Compounds o... |
|
|
Invention
|
N-alkyl-4-methyleneamino-3-hydroxy-2-pyridones as antimicrobials.
Compounds of Formula... |
|
|
Invention
|
N-alkyl-4-methyleneamino-3-hydroxy-2-pyridones.
are effective in the treatment of a microbial in... |
|
|
Invention
|
N-sulfonyl-4-methyleneamino-3-hydroxy-2-pyridones.
are effective in the treatment of a microbial... |
